Dear Readers,
The intersection of healthcare and competition law continues to evolve under the pressure of political change, scientific innovation, and economic concentration. The present Chronicle addresses pressing antitrust and regulatory themes in the healthcare and pharmaceutical sectors across multiple jurisdictions. From anticipated enforcement shifts in a new U.S. administration to emerging theories of harm like monopsony and product hopping, the contributions here offer rigorous
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 193.68.89.183
Please verify email or join us to access premium content!